Skip to search formSkip to main contentSkip to account menu

Benzbromarone

Known as: Benzbromaron, Benzbromarone [Chemical/Ingredient], Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)- 
Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Highly Cited
2010
Highly Cited
2010
Background—Hyperuricemia is common in chronic heart failure (CHF), and it is a strong independent marker of prognosis… 
Highly Cited
2010
Highly Cited
2010
Background— Hyperuricemia is common in chronic heart failure (CHF), and it is a strong independent marker of prognosis… 
Review
2008
Review
2008
Benzbromarone, a potent uricosuric drug, was introduced in the 1970s and was viewed as having few associated serious adverse… 
Highly Cited
2007
Highly Cited
2007
We report a 74-year-old man with acute on chronic tophaceous gout in whom conventional treatments failed but who responded to… 
Highly Cited
2006
Highly Cited
2006
The worldwide epidemic of metabolic syndrome correlates with an elevation in serum uric acid as well as a marked increase in… 
Review
2006
Review
2006
Objective: To develop evidence based recommendations for the management of gout. Methods: The multidisciplinary guideline… 
Highly Cited
2003
Highly Cited
2003
OBJECTIVE To validate the 19-item Compliance-Questionnaire-Rheumatology (CQR) against the "gold standard" in compliance… 
Highly Cited
2002
Highly Cited
2002
OBJECTIVE The optimal serum urate levels necessary for elimination of tissue deposits of monosodium urate in patients with… 
Highly Cited
1998
Highly Cited
1998
OBJECTIVES To study the efficacy of allopurinol and benzbromarone to reduce serum urate concentrations in patients with primary…